Xylem Director Sale: 1,700 Shares; Post-trade 16,875 Held

Q: What insider transaction did Xylem (XYL) disclose?

A director, Victoria D. Harker , reported selling 1,700 shares of Xylem common stock.

Q: At what price were the Xylem (XYL) shares sold?

The sale occurred at a weighted average price of $148.14 , within a range of $148.135 to $148.135 .

Q: When did the Xylem (XYL) insider sale occur?

The transaction date was November 4, 2025 .

Q: How many Xylem (XYL) shares does the insider hold after the sale?

Post-transaction, the director beneficially owns 16,875 shares directly.

Q: What is the reporting person’s relationship to Xylem (XYL)?

The reporting person is a Director of Xylem Inc.

Q: Were any derivative securities involved in this Xylem (XYL) filing?

The filing lists no derivative securities transactions in Table II.

Q: Was the Xylem (XYL) trade a direct or indirect holding?

The post-transaction ownership is reported as Direct (D) .

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Xylem Inc. (XYL) director Victoria D. Harker reported an open‑market sale of 1,700 shares of common stock at a weighted average price of $148.14 on November 4, 2025. According to the Form 4, the shares were executed within a price range of $148.135 to $148.135.

Following the transaction, Harker beneficially owns 16,875 shares directly. The filing lists no derivative securities transactions.

Insider Trade Summary

Net Seller: 1,700 shares

Net Sell 1 txn

Insider Harker Victoria D

Role Director

Sold 1,700 shs ($252K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,700	$148.14	$252K

Holdings After Transaction: Common Stock — 16,875 shares (Direct)

Footnotes (1)

F1. This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,700 Shares were executed at a range of prices from $148.135 to $148.135. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 11/05/2025 - 04:16 PM

FAQ

What insider transaction did Xylem (XYL) disclose?

A director, Victoria D. Harker, reported selling 1,700 shares of Xylem common stock.

At what price were the Xylem (XYL) shares sold?

The sale occurred at a weighted average price of $148.14, within a range of $148.135 to $148.135.

When did the Xylem (XYL) insider sale occur?

The transaction date was November 4, 2025.

How many Xylem (XYL) shares does the insider hold after the sale?

Post-transaction, the director beneficially owns 16,875 shares directly.

What is the reporting person’s relationship to Xylem (XYL)?

The reporting person is a Director of Xylem Inc.

Were any derivative securities involved in this Xylem (XYL) filing?

The filing lists no derivative securities transactions in Table II.

Was the Xylem (XYL) trade a direct or indirect holding?

The post-transaction ownership is reported as Direct (D).

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Harker Victoria D

(Last)

(First)

(Middle)

C/O XYLEM INC.

301 WATER STREET SE

(Street)

WASHINGTON

20003

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Xylem Inc. [ XYL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/04/2025		S		1,700	D	$148.14⁽¹⁾	16,875	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,700 Shares were executed at a range of prices from $148.135 to $148.135. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

	/s/ Mike Nazario, by power of attorney for Victoria D. Harker	11/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR